Suppr超能文献

多种肿瘤抑制因子通过 ISGF3 在人透明细胞肾细胞癌中调节 HIF 依赖性负反馈回路。

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer.

机构信息

Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Pennsylvania, United States.

Department of Pathology, Yale University, Connecticut, United States.

出版信息

Elife. 2018 Oct 25;7:e37925. doi: 10.7554/eLife.37925.

Abstract

Whereas inactivation is a primary event in clear cell renal cell carcinoma (ccRCC), the precise mechanism(s) of how this interacts with the secondary mutations in tumor suppressor genes, including , /, , and/or , remains unclear. Gene expression analyses reveal that VHL, PBRM1, or KDM5C share a common regulation of interferon response expression signature. Loss of HIF2α, PBRM1, or KDM5C in cells reduces the expression of interferon stimulated gene factor 3 (ISGF3), a transcription factor that regulates the interferon signature. Moreover, loss of SETD2 or BAP1 also reduces the ISGF3 level. Finally, ISGF3 is strongly tumor-suppressive in a xenograft model as its loss significantly enhances tumor growth. Conversely, reactivation of ISGF3 retards tumor growth by PBRM1-deficient ccRCC cells. Thus after inactivation, HIF induces ISGF3, which is reversed by the loss of secondary tumor suppressors, suggesting that this is a key negative feedback loop in ccRCC.

摘要

虽然失活是透明细胞肾细胞癌 (ccRCC) 的主要事件,但它与肿瘤抑制基因中的二次突变(包括 、 、 和/或 )相互作用的确切机制尚不清楚。基因表达分析表明,VHL、PBRM1 或 KDM5C 共同调控干扰素反应表达特征。细胞中 HIF2α、PBRM1 或 KDM5C 的缺失会降低干扰素刺激基因因子 3 (ISGF3) 的表达,ISGF3 是一种调节干扰素特征的转录因子。此外,SETD2 或 BAP1 的缺失也会降低 ISGF3 水平。最后,ISGF3 在异种移植模型中具有强烈的肿瘤抑制作用,因为其缺失显著增强了肿瘤生长。相反,ISGF3 的重新激活会通过 PBRM1 缺陷型 ccRCC 细胞来减缓肿瘤生长。因此,在 失活后,HIF 诱导 ISGF3,而二次肿瘤抑制因子的缺失会逆转这种情况,这表明这是 ccRCC 中的一个关键负反馈回路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2565/6234029/8a36b674bb86/elife-37925-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验